Search

Your search keyword '"Lawrance, I"' showing total 192 results

Search Constraints

Start Over You searched for: Author "Lawrance, I" Remove constraint Author: "Lawrance, I"
192 results on '"Lawrance, I"'

Search Results

1. Stability improvement of power distribution system using voltage stability factor compared with voltage stability index by compensation the capacitor size.

3. P1129 Fistulising Crohn's Disease in a large Australasian cohort - Crohn's Colitis Cure (CCC) Data Insights Program

4. P880 The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn’s Colitis Cure (CCC) data insight’s program

5. P462 The burden of mental health disease in people with inflammatory bowel disease - Crohn's Colitis Cure (CCC) Data Insights Program

6. P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program

7. P959 Dose escalated vedolizumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program

8. P1012 Dose escalated Ustekinumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program

9. P1005 Dose escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program

12. Infliximab vs. adalimumab in Crohnʼs disease: results from 327 patients in an Australian and New Zealand observational cohort study

15. Efficacy of thiopurines and adalimumab in preventing Crohnʼs disease recurrence in high-risk patients – a POCER study analysis

20. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

21. Faecal calprotectin helps determine the need for post-operative colonoscopy in crohnʼs disease. prospective longitudinal endoscopic validation. Results from the POCER study

23. Smoking is the key risk factor that doubles the risk of postoperative recurrence of Crohnʼs disease despite preventive drug treatment. Results from the POCER study

24. Optimising postoperative Crohnʼs disease management: Best drug therapy alone versus endoscopic monitoring with treatment step-up. The pocer study

25. Strategic timing of anti-TNF therapy in postoperative Crohnʼs disease: Comparison of routine use immediately postoperatively with selective use after demonstrated recurrence at 6 month endoscopy. Results from POCER

Catalog

Books, media, physical & digital resources